Special Issue "Fungal Infections in COVID-19 Patients"
Deadline for manuscript submissions: closed (20 May 2023) | Viewed by 10363
Interests: infectious diseases; invasive aspergillosis; cryptococcosis; histoplasmosis; fungal infections in immunocompromised hosts
2. Malattie Infettive, Azienda Ospedaliera Ospedali Marche Nord, 60121 Pesaro, Italy
Interests: antifungal resistance; invasive candidiasis; fungal pathogenesis; invasive aspergillosis; antifungal susceptibility tests
Invasive fungal infections have emerged as important opportunistic diseases among hospitalized subjects affected by severe COVID19. COVID-associated pulmonary aspergillosis (CAPA) has been reported as the leading invasive mycoses, with an incidence ranging from 3 to 35% in mechanically ventilated critically ill patients. However, such wide differences are probably related to different diagnostic criteria adopted with the difficult to separate true invasive disease from colonization. Moreover, more than 3000 cases of rhino-orbitocerebral mucormycosis (CAM) have been descibed in the literature especially in India, as well as in several other countries, suggesting the possibility of an emerging global problem. Candidemia, a frequent secondary infection among ICU-hospitalized patients, has been also increasingly observed in COVID-19 with high mortality; however, it is presently unknown if, besides well-known classical risk factors, specific risk factors for COVID-19 are responsible of its occurrence in this setting. Other invasive fungal infections (i.e., histoplasmosis, cryptococcosis, pneumocystosis, and coccidioidomycosis) have been reported, but are less well characterized among COVID-19 patients.
In this Special Issue, original research articles, reviews, systematic reviews, meta-studies, and case reports on such topics are welcome. Research areas may include the following:
- Clinical presentation
- Diagnostic methods
- Antifungal therapy
- Autopsy findings
Prof. Dr. Spinello Antinori
Prof. Dr. Francesco Barchiesi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Fungi is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- endemic mycoses